Vanessa Brès

2.4k total citations · 1 hit paper
19 papers, 1.8k citations indexed

About

Vanessa Brès is a scholar working on Molecular Biology, Infectious Diseases and Virology. According to data from OpenAlex, Vanessa Brès has authored 19 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Infectious Diseases and 6 papers in Virology. Recurrent topics in Vanessa Brès's work include HIV Research and Treatment (6 papers), Viral Infections and Vectors (5 papers) and Vector-borne infectious diseases (4 papers). Vanessa Brès is often cited by papers focused on HIV Research and Treatment (6 papers), Viral Infections and Vectors (5 papers) and Vector-borne infectious diseases (4 papers). Vanessa Brès collaborates with scholars based in United States, France and Democratic Republic of the Congo. Vanessa Brès's co-authors include Katherine A. Jones, Stéphane Emiliani, Rosemary Kiernan, Monsef Benkirane, Sunnie M. Yoh, Selma El Messaoudi, Dong‐Yan Jin, Raymond W. M. Ng, Loni Pickle and Jeffrey M. Linnen and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Neuroscience and Genes & Development.

In The Last Decade

Vanessa Brès

19 papers receiving 1.8k citations

Hit Papers

Rapid metagenomic identification of viral pathogens in cl... 2015 2026 2018 2022 2015 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vanessa Brès United States 14 1.0k 366 317 274 210 19 1.8k
Kathleen Börner Germany 19 1.2k 1.2× 273 0.7× 329 1.0× 250 0.9× 159 0.8× 31 1.8k
Luis L. P. daSilva Brazil 27 1.7k 1.7× 299 0.8× 259 0.8× 549 2.0× 220 1.0× 61 2.9k
Heiner Schaal Germany 29 1.8k 1.8× 661 1.8× 558 1.8× 346 1.3× 203 1.0× 102 3.2k
Stefanie Czub Canada 25 947 0.9× 481 1.3× 347 1.1× 430 1.6× 121 0.6× 73 2.4k
Jia Chen China 29 1.4k 1.4× 160 0.4× 224 0.7× 508 1.9× 105 0.5× 99 2.8k
Toshiaki Nikai Japan 27 1.0k 1.0× 364 1.0× 243 0.8× 174 0.6× 116 0.6× 126 2.3k
Xuhui Zhu China 23 697 0.7× 171 0.5× 117 0.4× 417 1.5× 228 1.1× 58 1.7k
Andrew W. Tai United States 29 1.2k 1.2× 351 1.0× 160 0.5× 326 1.2× 67 0.3× 55 2.6k
Yanhua Du China 26 846 0.8× 808 2.2× 106 0.3× 215 0.8× 289 1.4× 82 2.2k
Xuehua Xu United States 24 879 0.9× 251 0.7× 238 0.8× 473 1.7× 66 0.3× 70 2.0k

Countries citing papers authored by Vanessa Brès

Since Specialization
Citations

This map shows the geographic impact of Vanessa Brès's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vanessa Brès with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vanessa Brès more than expected).

Fields of papers citing papers by Vanessa Brès

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vanessa Brès. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vanessa Brès. The network helps show where Vanessa Brès may publish in the future.

Co-authorship network of co-authors of Vanessa Brès

This figure shows the co-authorship network connecting the top 25 collaborators of Vanessa Brès. A scholar is included among the top collaborators of Vanessa Brès based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vanessa Brès. Vanessa Brès is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Sauleda, Sílvia, Lourdes Palacios, Vanessa Brès, et al.. (2021). Clinical evaluation of the Procleix SARS-CoV-2 assay, a sensitive, high-throughput test that runs on an automated system. Diagnostic Microbiology and Infectious Disease. 102(1). 115560–115560. 9 indexed citations
2.
Bloch, Evan M., Zakayo Mrango, Mabula Kasubi, et al.. (2019). The Babesia observational antibody (BAOBAB) study: A cross-sectional evaluation of Babesia in two communities in Kilosa district, Tanzania. PLoS neglected tropical diseases. 13(8). e0007632–e0007632. 5 indexed citations
3.
Tonnetti, Laura, Carolyn Young, Debra Kessler, et al.. (2019). Transcription‐mediated amplification blood donation screening for Babesia. Transfusion. 60(2). 317–325. 16 indexed citations
4.
Tonnetti, Laura, Sheila F. O’Brien, Yves Grégoire, et al.. (2019). Prevalence of Babesia in Canadian blood donors: June–October 2018. Transfusion. 59(10). 3171–3176. 13 indexed citations
5.
Bakkour, Sonia, Daniel M. Chafets, Wen Li, et al.. (2018). Minimal infectious dose and dynamics of Babesia microti parasitemia in a murine model. Transfusion. 58(12). 2903–2910. 8 indexed citations
6.
Simmons, Graham, Vanessa Brès, Kai Lü, et al.. (2016). High Incidence of Chikungunya Virus and Frequency of Viremic Blood Donations during Epidemic, Puerto Rico, USA, 2014. Emerging infectious diseases. 22(7). 1221–1228. 79 indexed citations
7.
Greninger, Alexander L., Samia N. Naccache, Scot Federman, et al.. (2015). Rapid metagenomic identification of viral pathogens in clinical samples by real-time nanopore sequencing analysis. Genome Medicine. 7(1). 99–99. 353 indexed citations breakdown →
8.
Chiu, Charles Y., Vanessa Brès, Guixia Yu, et al.. (2015). Genomic Assays for Identification of Chikungunya Virus in Blood Donors, Puerto Rico, 2014. Emerging infectious diseases. 21(8). 1409–1413. 32 indexed citations
10.
Brès, Vanessa, Tomonori Yoshida, Loni Pickle, & Katherine A. Jones. (2009). SKIP Interacts with c-Myc and Menin to Promote HIV-1 Tat Transactivation. Molecular Cell. 36(1). 75–87. 59 indexed citations
11.
Brès, Vanessa, Sunnie M. Yoh, & Katherine A. Jones. (2008). The multi-tasking P-TEFb complex. Current Opinion in Cell Biology. 20(3). 334–340. 183 indexed citations
12.
Brès, Vanessa, et al.. (2006). Requirement for SWI/SNF chromatin‐remodeling complex in Tat‐mediated activation of the HIV‐1 promoter. The EMBO Journal. 25(8). 1690–1699. 141 indexed citations
13.
Brès, Vanessa, Nathan Gomes, Loni Pickle, & Katherine A. Jones. (2005). A human splicing factor, SKIP, associates with P-TEFb and enhances transcription elongation by HIV-1 Tat. Genes & Development. 19(10). 1211–1226. 91 indexed citations
14.
Brès, Vanessa, Rosemary Kiernan, Laëtitia K. Linares, et al.. (2003). A non-proteolytic role for ubiquitin in Tat-mediated transactivation of the HIV-1 promoter. Nature Cell Biology. 5(8). 754–761. 152 indexed citations
15.
Kiernan, Rosemary, Vanessa Brès, Raymond W. M. Ng, et al.. (2003). Post-activation Turn-off of NF-κB-dependent Transcription Is Regulated by Acetylation of p65. Journal of Biological Chemistry. 278(4). 2758–2766. 444 indexed citations
16.
Hussy, Nicolas, Charlotte Deleuze, Vanessa Brès, & F. Moos. (2002). New Role of Taurine as an Osmomediator between Glial Cells and Neurons in the Rat Supraoptic Nucleus. Advances in experimental medicine and biology. 483. 227–237. 19 indexed citations
17.
Brès, Vanessa, Rosemary Kiernan, Stéphane Emiliani, & Monsef Benkirane. (2002). Tat Acetyl-acceptor Lysines Are Important for Human Immunodeficiency Virus Type-1 Replication. Journal of Biological Chemistry. 277(25). 22215–22221. 43 indexed citations
18.
Hussy, Nicolas, Vanessa Brès, Anne Duvoid, et al.. (2001). Osmoregulation of Vasopressin Secretion via Activation of Neurohypophysial Nerve Terminals Glycine Receptors by Glial Taurine. Journal of Neuroscience. 21(18). 7110–7116. 88 indexed citations
19.
Brès, Vanessa, Amandine Hurbin, Anne Duvoid, et al.. (2000). Pharmacological characterization of volume‐sensitive, taurine permeable anion channels in rat supraoptic glial cells. British Journal of Pharmacology. 130(8). 1976–1982. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026